Identification of FoxM1/Bub1b signaling pathway as a required component for growth and survival of rhabdomyosarcoma.
about
FOXM1 in sarcoma: role in cell cycle, pluripotency genes and stem cell pathwaysIGF-1R Inhibition Activates a YES/SFK Bypass Resistance Pathway: Rational Basis for Co-Targeting IGF-1R and Yes/SFK Kinase in Rhabdomyosarcoma.Prognostic significance of FOXM1 expression and antitumor effect of FOXM1 inhibition in synovial sarcomasExpression of Forkhead box M1 in soft tissue leiomyosarcoma: Clinicopathologic and in vitro study using a newly established cell line.Network analysis reveals potential markers for pediatric adrenocortical carcinomaIdentification of cell cycle-regulated genes periodically expressed in U2OS cells and their regulation by FOXM1 and E2F transcription factors.The Role of PDGFR-β Activation in Acquired Resistance to IGF-1R Blockade in Preclinical Models of Rhabdomyosarcoma.STA-8666, a novel HSP90 inhibitor/SN-38 drug conjugate, causes complete tumor regression in preclinical mouse models of pediatric sarcoma.Proof-of-concept rare cancers in drug development: the case for rhabdomyosarcoma.Insights into a Critical Role of the FOXO3a-FOXM1 Axis in DNA Damage Response and Genotoxic Drug Resistance.The importance of being dead: cell death mechanisms assessment in anti-sarcoma therapy.FOXM1 expression in rhabdomyosarcoma: a novel prognostic factor and therapeutic target.RNAi-based functional selection identifies novel cell migration determinants dependent on PI3K and AKT pathways.The FOXM1/BUB1B signaling pathway is essential for the tumorigenicity and radioresistance of glioblastoma.Overexpression of forkhead box M1 and urokinase-type plasminogen activator in gastric cancer is associated with cancer progression and poor prognosis.Novel target genes responsive to apoptotic activity by Ocimum gratissimum in human osteosarcoma cells.
P2860
Q28076296-0F43539A-4068-47C1-A68B-6A1432DC9254Q35555492-BAD2D93B-04DC-4EB4-9503-CACB1C582256Q36083264-E0EAAE55-A4B4-4F2F-A0D5-D344174A79B5Q36495922-A4887C9C-01D9-4C8E-B5B4-68139C7985ECQ37143014-3CC58743-A3AD-4A51-BF56-1E7EB0366478Q37348740-AE81BC67-3334-4D9F-ACD0-43E07C82CD5FQ37421580-15334A51-F821-4A94-B8FA-5194AEFBA400Q37662264-7B891F68-90C9-4A72-B2A4-8B6EDCFE4F55Q38105879-036F2634-8356-4819-86E2-3824ECDB1146Q38270775-A55747AE-70B8-46D6-A8FD-3B7C6ED042B6Q38437281-D2D5BC3E-DEB3-4986-8D46-9951C491EB42Q38820614-5FB695D0-51B6-4258-95D9-6939EF1C2D38Q42834164-A3F6EC4A-7310-41FB-BDFD-D54BD253F576Q47640908-38B7F7B2-215D-4223-ACE2-5A7CA830C1B3Q47654322-E36EBEDD-7F95-4D72-8241-7383DD9701BDQ53047125-D1A0108B-644D-4CFB-852F-FF25ED1F95C5
P2860
Identification of FoxM1/Bub1b signaling pathway as a required component for growth and survival of rhabdomyosarcoma.
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Identification of FoxM1/Bub1b ...... survival of rhabdomyosarcoma.
@ast
Identification of FoxM1/Bub1b ...... survival of rhabdomyosarcoma.
@en
Identification of FoxM1/Bub1b ...... survival of rhabdomyosarcoma.
@nl
type
label
Identification of FoxM1/Bub1b ...... survival of rhabdomyosarcoma.
@ast
Identification of FoxM1/Bub1b ...... survival of rhabdomyosarcoma.
@en
Identification of FoxM1/Bub1b ...... survival of rhabdomyosarcoma.
@nl
prefLabel
Identification of FoxM1/Bub1b ...... survival of rhabdomyosarcoma.
@ast
Identification of FoxM1/Bub1b ...... survival of rhabdomyosarcoma.
@en
Identification of FoxM1/Bub1b ...... survival of rhabdomyosarcoma.
@nl
P2093
P2860
P1433
P1476
Identification of FoxM1/Bub1b ...... survival of rhabdomyosarcoma.
@en
P2093
Choh Yeung
Javed Khan
Joseph G Dolan
Lee J Helman
Louis M Staudt
Sandra Burkett
Su Young Kim
Xiaolin Wan
P2860
P304
P356
10.1158/0008-5472.CAN-12-1991
P407
P577
2012-09-20T00:00:00Z